Venclexta and Lidoderm drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Venclexta (venetoclax) and Lidoderm (lidocaine). Common drug interactions include general physical health deterioration among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Venclexta and Lidoderm. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Venclexta?

Venclexta has active ingredients of venetoclax. eHealthMe is studying from 31,425 Venclexta users. Check the latest studies of Venclexta.

What is Lidoderm?

Lidoderm has active ingredients of lidocaine. It is often used in pain. eHealthMe is studying from 10,524 Lidoderm users. Check the latest studies of Lidoderm.



On Jul, 17, 2026

39 people who take Venclexta and Lidoderm together, and have interactions are studied.

Venclexta and Lidoderm drug interactions.

What are the common drug interactions of Venclexta and Lidoderm, by gender? *:

female:

  1. General physical health deterioration (weak health status)
  2. Hospitalisation
  3. Thoracic haemorrhage (bleeding from chest cavity)
  4. Death
  5. Platelet count decreased
  6. Nausea (feeling of having an urge to vomit)
  7. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  8. Cardiac disorder
  9. Aphasia (damage to the parts of the brain that control language)
  10. Chronic lymphocytic leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell))

male:

  1. Death
  2. Retinal tear
  3. Arthralgia (joint pain)
  4. Bipolar i disorder (mood disorder that is characterized by at least one manic or mixed episode)
  5. Blood uric acid increased
  6. Chills (felling of cold)
  7. Compartment syndrome (painful condition that occurs when pressure within the muscles builds to dangerous levels)
  8. Corneal scar (nullah)
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Dry eye (lack of adequate tears)

What are the common drug interactions of Venclexta and Lidoderm, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Infectious pleural effusion (infectious fluid in the lung)
  2. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  3. Post procedural infection
  4. Death
  5. Arthralgia (joint pain)
  6. Malaise (a feeling of general discomfort or uneasiness)

60+:

  1. White blood cell count decreased
  2. Nausea (feeling of having an urge to vomit)
  3. Rash
  4. Arthritis infective (purulent invasion of a joint by an infectious agent which produces arthritis)
  5. Chronic lymphocytic leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell))
  6. Dysphagia (a condition in which swallowing is difficult or painful)
  7. Infection
  8. Joint swelling
  9. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  10. Organ failure

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 13 people, 33.33%
  2. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 8 people, 20.51%
  3. Constipation: 5 people, 12.82%
  4. Multiple Myeloma (cancer of the plasma cells): 4 people, 10.26%
  5. Nausea (feeling of having an urge to vomit): 3 people, 7.69%
  6. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 7.69%
  7. Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 2 people, 5.13%
  8. Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 2 people, 5.13%
  9. Dyspnea (difficult or laboured breathing): 2 people, 5.13%
  10. Cough: 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Venclexta and Lidoderm?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Venclexta and Lidoderm:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Venclexta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lidoderm:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Venclexta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lidoderm and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on venetoclax and lidocaine (the active ingredients of Venclexta and Lidoderm, respectively), and Venclexta and Lidoderm (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: